• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Lithobid (lithium carbonate) Extended-Release tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011

 

Summary View

 

WARNINGS

  • the unmasking of Brugada Syndrome [added]

 

ADVERSE REACTIONS

  • the unmasking of Brugada Syndrome [added]

 

PATIENT COUNSELING INFORMATION

  • the unmasking of Brugada Syndrome [added]